FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
40.54 EUR
+0.92 (+2.32%)
FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 31 industry peers in the Health Care Providers & Services industry. FME has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on FME.
1. Profitability
1.1 Basic Checks
In the past year FME was profitable.
In the past year FME had a positive cash flow from operations.
In the past 5 years FME has always been profitable.
FME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
FME has a Return On Assets of 2.10%. This is comparable to the rest of the industry: FME outperforms 48.39% of its industry peers.
The Return On Equity of FME (4.95%) is comparable to the rest of the industry.
FME's Return On Invested Capital of 3.84% is in line compared to the rest of the industry. FME outperforms 41.94% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FME is below the industry average of 6.75%.
The last Return On Invested Capital (3.84%) for FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROIC | 3.84% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
FME's Profit Margin of 3.36% is fine compared to the rest of the industry. FME outperforms 61.29% of its industry peers.
In the last couple of years the Profit Margin of FME has declined.
FME has a Operating Margin of 7.15%. This is comparable to the rest of the industry: FME outperforms 58.06% of its industry peers.
FME's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 24.67%, FME is in line with its industry, outperforming 51.61% of the companies in the same industry.
In the last couple of years the Gross Margin of FME has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FME is destroying value.
The number of shares outstanding for FME remains at a similar level compared to 1 year ago.
The number of shares outstanding for FME has been reduced compared to 5 years ago.
Compared to 1 year ago, FME has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.15 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.15, FME is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
FME has a debt to FCF ratio of 5.47. This is a neutral value as FME would need 5.47 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.47, FME is doing good in the industry, outperforming 70.97% of the companies in the same industry.
FME has a Debt/Equity ratio of 0.71. This is a neutral value indicating FME is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.71, FME is doing good in the industry, outperforming 67.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Altman-Z | 2.15 |
ROIC/WACC0.67
WACC5.7%
2.3 Liquidity
FME has a Current Ratio of 1.44. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of FME (1.44) is better than 74.19% of its industry peers.
A Quick Ratio of 1.08 indicates that FME should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.08, FME is doing good in the industry, outperforming 67.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
FME shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.08%.
The Earnings Per Share has been decreasing by -6.43% on average over the past years.
Looking at the last year, FME shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)-0.08%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%-32.02%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%4.49%
3.2 Future
FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.70% yearly.
Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 3.96% on average per year.
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.59 indicates a correct valuation of FME.
Based on the Price/Earnings ratio, FME is valued cheaply inside the industry as 80.65% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.45. FME is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 9.79, which indicates a very decent valuation of FME.
FME's Price/Forward Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 90.32% of the companies in the same industry.
FME is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.59 | ||
| Fwd PE | 9.79 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FME.
Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than the industry average as 70.97% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.81 | ||
| EV/EBITDA | 10.5 |
4.3 Compensation for Growth
FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FME's earnings are expected to grow with 13.44% in the coming years.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y12.9%
EPS Next 3Y13.44%
5. Dividend
5.1 Amount
FME has a Yearly Dividend Yield of 3.63%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.44, FME pays a better dividend. On top of this FME pays more dividend than 96.77% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, FME pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.63% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
64.37% of the earnings are spent on dividend by FME. This is not a sustainable payout ratio.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP64.37%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
FRA:FME (11/21/2025, 7:00:00 PM)
40.54
+0.92 (+2.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.79B
Revenue(TTM)19.34B
Net Income(TTM)656.42M
Analysts65.6
Price Target48.43 (19.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.63% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP64.37%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.03%
Min EPS beat(2)14.89%
Max EPS beat(2)27.17%
EPS beat(4)4
Avg EPS beat(4)20.72%
Min EPS beat(4)14.89%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)15.78%
EPS beat(12)10
Avg EPS beat(12)13.92%
EPS beat(16)12
Avg EPS beat(16)10.11%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)2.74%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-1.72%
PT rev (3m)-4.31%
EPS NQ rev (1m)8.29%
EPS NQ rev (3m)6.47%
EPS NY rev (1m)0.52%
EPS NY rev (3m)3.82%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.59 | ||
| Fwd PE | 9.79 | ||
| P/S | 1.22 | ||
| P/FCF | 11.81 | ||
| P/OCF | 8.64 | ||
| P/B | 1.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.5 |
EPS(TTM)3.22
EY7.94%
EPS(NY)4.14
Fwd EY10.22%
FCF(TTM)3.43
FCFY8.47%
OCF(TTM)4.69
OCFY11.58%
SpS33.26
BVpS22.61
TBVpS-2.73
PEG (NY)0.69
PEG (5Y)N/A
Graham Number40.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROCE | 5.44% | ||
| ROIC | 3.84% | ||
| ROICexc | 4.19% | ||
| ROICexgc | 11.45% | ||
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% | ||
| FCFM | 10.32% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Debt/EBITDA | 3.14 | ||
| Cap/Depr | 45.83% | ||
| Cap/Sales | 3.79% | ||
| Interest Coverage | 3.82 | ||
| Cash Conversion | 91.56% | ||
| Profit Quality | 307% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.15 |
F-Score6
WACC5.7%
ROIC/WACC0.67
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.08%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%-32.02%
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%4.49%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
EBIT growth 1Y2.71%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y19.09%
FCF growth 1Y14.07%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y14.41%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 12.59 and the Price/Book (PB) ratio is 1.79.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 6 / 10 and the dividend payout ratio is 64.37%.